J3 Bioscience
Salt Lake City, US · Utah corporation
J3 Bioscience develops LivRing, a patented intravaginal ring platform for sustained, controlled release of active and functional ingredients, licensed exclusively and globally from the University of Utah. The system targets women's health with localized or systemic delivery as an alternative to oral dosage forms for direct-to-consumer indications.
Founders & leadership
TS
Tim S. GlassettExecutive
JF
John FairExecutive
RT
R. Tyler McCabeExecutive
Board
SJ
Stath J. KarrasBoard director
KM
Keith MarmerBoard director
DJ
Duck Joo LeeBoard director
RN
Ron NielsenBoard director
SS
Stephanie SingerBoard director
TE
Troy E. MasonBoard director
SA
Sheryl A. KingsbergBoard director
JF
Jayne F. CarneyBoard director
LD
Larry D. RigbyBoard director
Reported raises · per SEC filings
Form D private placements$5.7M disclosed across 10 rounds · 2013–2023
▶$1.7MraisedAug 2026 · 23 investors · Other Health CareRule 506(b)
▶$1.7MraisedAug 2026 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- R. Tyler McCabeExecutive Officer, Director
- Tim S. GlassettExecutive Officer, Director
- Stath J. KarrasDirector
- Duck Joo LeeDirector
- Troy E. MasonDirector
- Ron E. NielsenDirector
- Sheryl A. KingsbergDirector
- Keith MarmerDirector
- Stephanie SingerDirector
- Offering amount
- $2.8M
- Amount sold
- $1.7M
- Minimum investment
- $10K
- Proceeds to insiders
- $900K
- First sale
- Oct 2023
- Incorporated
- Corporation, Utah
- Federal exemptions
- 06b
▶$50KraisedJun 2023 · 1 investors · Other Health CareRule 506(b)
▶$50KraisedJun 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tim S. GlassettExecutive Officer, Director
- Ron NielsenDirector
- Duck Joo LeeDirector
- Troy E. MasonDirector
- Stath J. KarrasDirector
- Jayne F, CarneyDirector
- R. Tyler McCabeExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $50K
- Minimum investment
- $10K
- Proceeds to insiders
- $279K
- First sale
- Jun 2023
- Incorporated
- Corporation, Utah
- Federal exemptions
- 06b
▶$316.8KraisedNov 2022 · 6 investors · Other Health CareRule 506(b)
▶$316.8KraisedNov 2022 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stath J. KarrasDirector
- Duck Joo LeeDirector
- Tim S. GlassettExecutive Officer, Director
- R. Tyler McCabeExecutive Officer, Director
- Jayne F, CarneyDirector
- Ron NielsenDirector
- Troy E. MasonDirector
- Offering amount
- $1M
- Amount sold
- $316.8K
- Minimum investment
- $10K
- Proceeds to insiders
- $276K
- First sale
- Mar 2022
- Incorporated
- Corporation, Utah
- Federal exemptions
- 06b
▶$530KraisedMay 2021 · 5 investors · Other Health CareRule 506(b)
▶$530KraisedMay 2021 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tim S. GlassettDirector
- Jayne F. CarneyDirector
- Larry D. RigbyDirector
- Duck Joo LeeDirector
- R. Tyler McCabeExecutive Officer, Director
- Offering amount
- $600K
- Amount sold
- $530K
- Minimum investment
- $10K
- Proceeds to insiders
- $105K
- First sale
- Apr 2021
- Incorporated
- Corporation, Utah
- Federal exemptions
- 06b
▶$605KraisedJul 2020 · 3 investors · Other Health CareRule 506(b)
▶$605KraisedJul 2020 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Duck Joo LeeDirector
- Tim S. GlassettExecutive Officer, Director
- R. Tyler McCabeExecutive Officer, Director
- Jayne F. CarneyDirector
- Larry D. RigbyDirector
- Offering amount
- $1M
- Amount sold
- $605K
- Minimum investment
- $10K
- Proceeds to insiders
- $138K
- First sale
- Jul 2020
- Incorporated
- Corporation, Utah
- Federal exemptions
- 06b
▶$20KraisedDec 2019 · 1 investors · Other Health CareRule 506(b)
▶$20KraisedDec 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- R. Tyler McCabeExecutive Officer, Director
- Larry D. RigbyDirector
- Tim S. GlassettDirector
- Duck Joo LeeDirector
- Jayne F. CarneyDirector
- Offering amount
- $500K
- Amount sold
- $20K
- Minimum investment
- $10K
- Proceeds to insiders
- $138K
- First sale
- Dec 2019
- Incorporated
- Corporation, Utah
- Federal exemptions
- 06b
▶$22.5KraisedMar 2019 · 1 investors · Other Health CareRule 506(b)
▶$22.5KraisedMar 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Larry D. RigbyDirector
- Jayne F. CarneyDirector
- R. Tyler McCabeExecutive Officer, Director
- Tim S. GlassettDirector
- Duck Joo LeeDirector
- Offering amount
- $600K
- Amount sold
- $22.5K
- Minimum investment
- $10K
- Proceeds to insiders
- $276K
- First sale
- Mar 2019
- Incorporated
- Corporation, Utah
- Federal exemptions
- 06b
▶$420KraisedDec 2018 · 5 investors · Other Health CareRule 506(b)
▶$420KraisedDec 2018 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tim S. GlassettDirector
- R. Tyler McCabeExecutive Officer, Director
- Duck Joo LeeDirector
- Larry D. RigbyDirector
- Jayne F. CarneyDirector
- Offering amount
- $900K
- Amount sold
- $420K
- Minimum investment
- $10K
- Proceeds to insiders
- $544K
- First sale
- Mar 2018
- Incorporated
- Corporation, Utah
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does J3 Bioscience do?
- J3 Bioscience develops LivRing, a patented intravaginal ring platform for sustained, controlled release of active and functional ingredients, licensed exclusively and globally from the University of Utah. The system targets women's health with localized or systemic delivery as an alternative to oral dosage forms for direct-to-consumer indications.
- How much funding has J3 Bioscience raised?
- J3 Bioscience has disclosed $5.7M raised across 10 rounds.
- Where is J3 Bioscience headquartered?
- J3 Bioscience is headquartered in Salt Lake City, US.